Private Companies and the Next Generation of Growth

Exploring why many of the world's most innovative companies now remain private for longer, and what this trend means for investors seeking exposure to emerging growth themes.

Executive Summary

A notable feature of recent decades has been the tendency of many innovative companies, particularly in technology and healthcare, to remain privately held well beyond the stage at which their predecessors might have pursued a public listing. This article explores the drivers behind this trend, what it means for investors seeking exposure to emerging growth themes, and the access, valuation and governance considerations that come with investing in later-stage private companies.

Market Context

The proliferation of specialist growth equity and late-stage venture funds, together with the willingness of institutional investors to commit substantial capital to private funding rounds, has enabled many companies to raise significant sums without listing publicly. This has been particularly pronounced in sectors characterised by rapid scaling potential and high research and development intensity, where founders may prioritise the flexibility and reduced disclosure obligations associated with remaining private.

Key Investment Considerations

For investors, this trend means that meaningful value creation in some of the most closely watched growth companies now occurs prior to, or entirely in the absence of, a public listing. Gaining exposure to this segment typically requires access to specialist private funds, secondary market transactions in private company shares, or, in some cases, structured vehicles designed to provide indirect exposure. Each avenue carries distinct considerations around cost, transparency and the rights afforded to investors.

Access to leading late-stage private companies is often the binding constraint for investors, not capital availability.

Valuations for late-stage private companies are typically set through negotiated funding rounds rather than continuous market pricing, and can be influenced by preferential terms granted to specific investor classes, such as liquidation preferences, which may not be immediately apparent from headline valuation figures. Investors should seek to understand the full capital structure and terms of any private company investment, rather than relying solely on a reported valuation.

Opportunities

For investors able to secure access, later-stage private companies can offer the potential to participate in growth trajectories before a public listing, alongside the possibility of a future liquidity event through an initial public offering or acquisition. This can complement listed growth exposure by providing a further diversification of vintage and stage within an overall growth allocation.

Risks

• Limited transparency around company financials and governance relative to listed peers.
• Uncertain timing and outcome of eventual liquidity events.
• Potential for down rounds or unfavourable structuring terms that dilute or subordinate certain investors.
• Concentration risk given the smaller number of holdings typical of direct private company exposure.
• Access is often limited to specific investor categories or minimum commitment sizes.

Outlook

The trend toward extended private ownership periods appears likely to persist while private capital remains abundant and available on competitive terms. Investors should expect continued innovation in structures designed to broaden access to this segment, alongside ongoing scrutiny of the governance and disclosure standards applied to late-stage private companies.

Conclusion

The extended private lifecycle of many innovative companies presents both an opportunity and a challenge for investors seeking exposure to emerging growth themes. Careful attention to access, valuation and governance is essential. This article is general information only and does not constitute personal financial advice.

Information contained within these insights is provided for general information purposes only and does not constitute personal financial advice, an offer or recommendation to acquire or dispose of any financial product. Investors should consider their individual circumstances and obtain appropriate professional advice before making investment decisions.